Compare XBIO & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIO | ABTS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | Hong Kong |
| Employees | 2 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.4M |
| IPO Year | N/A | 2021 |
| Metric | XBIO | ABTS |
|---|---|---|
| Price | $3.12 | $2.48 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.8K | ★ 51.5K |
| Earning Date | 03-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $1.35 |
| 52 Week High | $13.93 | $10.86 |
| Indicator | XBIO | ABTS |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 38.30 |
| Support Level | $2.64 | $2.06 |
| Resistance Level | $3.60 | $3.00 |
| Average True Range (ATR) | 0.26 | 0.21 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 74.42 | 28.77 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.